Ficker, Eckhard

The binding site for channel blockers that rescue misprocessed human long QT syndrome type 2 ether-a-gogo-related gene (HERG) mutations. [electronic resource] - The Journal of biological chemistry Feb 2002 - 4989-98 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

0021-9258

10.1074/jbc.M107345200 doi


Anti-Arrhythmia Agents--pharmacology
Astemizole--pharmacology
Benzimidazoles--pharmacology
Binding Sites
Blotting, Western
Cation Transport Proteins
Cell Line
Cell Membrane--metabolism
Cisapride--pharmacology
DNA-Binding Proteins
Dose-Response Relationship, Drug
ERG1 Potassium Channel
Electrophysiology
Ether-A-Go-Go Potassium Channels
Gastrointestinal Agents--pharmacology
Histamine H1 Antagonists--pharmacology
Humans
Inhibitory Concentration 50
Ions
Long QT Syndrome--genetics
Models, Chemical
Mutagenesis, Site-Directed
Mutation
Patch-Clamp Techniques
Piperidines--pharmacology
Potassium Channels--chemistry
Potassium Channels, Voltage-Gated
Protein Folding
Pyridines--pharmacology
Quaternary Ammonium Compounds--chemistry
Quinidine--pharmacology
Structure-Activity Relationship
Trans-Activators
Transcriptional Regulator ERG